BENDHEIM JACK (President and CEO) sold 58.7% of their position (72.20K shares) of PHIBRO ANIMAL HEALTH CORP on the open market
Open‑market sale worth $3.74M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 2/11/2026ACC: 0001104659-26-013602
DirectorOfficer10% Owner· President and CEO
Since Jul 2018
-72.20K
Net shares
Net seller
$3.74M
Total sold
4
Open market trades
0B · 4S
4
Total transactions
72.20K disposed
Non-Derivative Transactions4
Class A Common Stock
Indirect
Shares
−50.99K
Price / share
$51.76
Trade value
$2.64M
% of position
41.5%
2/10/2026
122.96K→71.96K
Class A Common Stock
Indirect
Shares
−7.02K
Price / share
$52.17
Trade value
$366.25K
% of position
9.8%
2/10/2026
71.96K→64.94K
Class A Common Stock
Indirect
Shares
−13.95K
Price / share
$51.61
Trade value
$719.97K
% of position
21.5%
2/11/2026
64.94K→50.99K
Class A Common Stock
Indirect
Shares
−234.00
Price / share
$52.21
Trade value
$12.22K
% of position
0.5%
2/11/2026
50.99K→50.76K
Total
Net shares
−72.20K
Net value
-$3.74M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Indirect | 2/10/2026 | S · Sale | −50.99K | $51.76 | $2.64M | 41.5% | 122.96K | 71.96K |
| Class A Common Stock Indirect | 2/10/2026 | S · Sale | −7.02K | $52.17 | $366.25K | 9.8% | 71.96K | 64.94K |
| Class A Common Stock Indirect | 2/11/2026 | S · Sale | −13.95K | $51.61 | $719.97K | 21.5% | 64.94K | 50.99K |
| Class A Common Stock Indirect | 2/11/2026 | S · Sale | −234.00 | $52.21 | $12.22K | 0.5% | 50.99K | 50.76K |
| Total | −72.20K | -$3.74M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Class A Common Stock
DirectShares owned16.84K
Total
16.84K direct16.84K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 16.84K | Direct |
| Total | 16.84K | 16.84K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported